Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CDKN2B anticorps

CDKN2B Reactivité: Humain WB, IF, IP Hôte: Souris Monoclonal 1F6 unconjugated
N° du produit ABIN1449282
  • Antigène Voir toutes CDKN2B Anticorps
    CDKN2B (Cyclin-Dependent Kinase Inhibitor 2B (p15, Inhibits CDK4) (CDKN2B))
    Reactivité
    • 69
    • 17
    • 16
    • 5
    • 2
    • 2
    • 2
    • 2
    • 1
    Humain
    Hôte
    • 59
    • 10
    • 1
    Souris
    Clonalité
    • 61
    • 9
    Monoclonal
    Conjugué
    • 34
    • 7
    • 7
    • 6
    • 5
    • 5
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp CDKN2B est non-conjugé
    Application
    • 57
    • 43
    • 38
    • 35
    • 25
    • 15
    • 6
    • 4
    • 2
    • 1
    Western Blotting (WB), Immunofluorescence (IF), Immunoprecipitation (IP)
    Specificité
    This antibody reacts with p15INK4b (15 kDa).
    Réactivité croisée (Details)
    Species reactivity (tested):Human (HeLa, 293T, transfectant), does not react with Mouse (NIH/3T3, P3U1) and Rat (PC12, Rat1)
    Purification
    Protein A agarose
    Immunogène
    GST-full length human p15INK4b
    Clone
    1F6
    Isotype
    IgG1
    Top Product
    Discover our top product CDKN2B Anticorps primaire
  • Indications d'application
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Concentration
    1.0 mg/mL
    Buffer
    PBS containing 50 % glycerol, pH 7.2. Contains no preservatives.
    Agent conservateur
    Without preservative
    Conseil sur la manipulation
    Avoid repeated freezing and thawing.
    Stock
    -20 °C
    Stockage commentaire
    Upon receipt, store (in aliqouts) at -20 °C.
  • Antigène
    CDKN2B (Cyclin-Dependent Kinase Inhibitor 2B (p15, Inhibits CDK4) (CDKN2B))
    Autre désignation
    CDKN2B / p15INK4b (CDKN2B Produits)
    Synonymes
    anticorps p14-INK4b, anticorps cdk4l, anticorps ink4b, anticorps mts2, anticorps p15, anticorps p15ink4b, anticorps tp15, anticorps CDK4I, anticorps INK4B, anticorps MTS2, anticorps P15, anticorps TP15, anticorps p15INK4b, anticorps AV083695, anticorps INK4b, anticorps p15(INK4b), anticorps CDKN2A, anticorps cyclin dependent kinase inhibitor 2B, anticorps Cyclin-dependent kinase 4 inhibitor B, anticorps cyclin-dependent kinase inhibitor 2B, anticorps cyclin-dependent kinase inhibitor 2B L homeolog, anticorps cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4), anticorps CDKN2B, anticorps cdn2b, anticorps cdkn2b, anticorps cdkn2b.L, anticorps Cdkn2b
    Sujet
    Progression through the G1 phase of the cell cycle is regulated in part by the D-type cyclin-dependent kinases, cdk4 and cdk6. p15INK4b is a specific inhibitor of cdk4/cdk6 and is periodically expressed during cell cycle. Induction of p15INK4b is important for TGFß-mediated cytostasis in epithelial cells but not in hematopoietic cells, it may act as an effector of TGF-ß mediated cell arrest.Synonyms: Cyclin-dependent kinase 4 inhibitor B, MTS2, Multiple tumor suppressor 2, p14-INK4b, p14INK4b, p15-INK4b
    ID gène
    1030
    NCBI Accession
    NP_004927
    UniProt
    P42772
    Pathways
    Cycle Cellulaire, Mitotic G1-G1/S Phases
Vous êtes ici:
Support technique